1,202 results on '"White, C. Michael"'
Search Results
2. Dangers of FDA Oversight of Clinical Trials in Developing Countries
3. Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis
4. Beneficial and Harmful Effects of Monoclonal Antibodies for the Treatment and Prophylaxis of COVID-19: Systematic Review and Meta-Analysis
5. The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease: A Systematic Review With Meta-analysis
6. Innovative partnership in Connecticut to expand health professional eligibility to administer COVID-19 vaccines
7. The Impact of Ketamine for Treatment of Post-Traumatic Stress Disorder: A Systematic Review With Meta-Analyses.
8. Eye Drop Quality Issues: Can the FDA See This One Through?
9. Popularly known as ‘gas station heroin,’ tianeptine is being sold as a dietary supplement – with deadly outcomes
10. How the pandemic set back drug safety
11. The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis
12. Developing Criteria and Associated Instructions for Consistent and Useful Quality Improvement Study Data Extraction for Health Systems
13. AHRQ Series on Improving Translation of Evidence: Linking Evidence Reports and Performance Measures to Help Learning Health Systems Use New Information for Improvement
14. CRISPR and other new technologies open doors for drug development, but which diseases get prioritized? It comes down to money and science
15. Effects of intermittent versus continuous dieting on weight and body composition in obese and overweight people: a systematic review and meta-analysis of randomized controlled trials
16. Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis
17. Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis.
18. The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis.
19. The Impact of Ketamine for Treatment of Post-Traumatic Stress Disorder: A Systematic Review With Meta-Analyses
20. Creatine supplementation does not alter the creatine kinase response to eccentric exercise in healthy adults on atorvastatin
21. FDA's big gamble on new Alzheimer drug
22. Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has Arrived
23. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain
24. The Impact of Sedative Hypnotic Drugs on Hallucinated Sexual Assault or Sexual Fantasies Involving Health Professionals: A Systematic Review
25. Psychedelics for Patients With Cancer: A Comprehensive Literature Review
26. Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has Arrived.
27. Developing Consistent and Useful Quality Improvement Study Data Extraction for Health Systems
28. Cardiovascular Medications and Exercise
29. A data-driven quality-score system for rating drug products and its implications for the health care industry
30. A proposed approach may help systematic reviews retain needed expertise while minimizing bias from nonfinancial conflicts of interest
31. Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation
32. Mavacamten, a First-in-Class Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy
33. Meta-Analysis to Assess the Quality of International Normalized Ratio Control and Associated Outcomes in Venous Thromboembolism Patients
34. Pharmacologic and clinical assessment of kratom
35. Special Considerations in Research
36. Mavacamten, a First-in-Class Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy.
37. New options when statins are not enough
38. Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis
39. Criminal Action Against Drug Counterfeiters: Assessment of the FDA Office of Criminal Investigation Database 2016 Through 2021
40. Inclisiran: A Novel Small Interfering RNA Drug for Low‐Density Lipoprotein Reduction
41. A randomized trial of coenzyme Q10 in patients with statin myopathy: Rationale and study design
42. The antihypertensive effects of aerobic versus isometric handgrip resistance exercise
43. Pharmacologic, Pharmacokinetic, and Clinical Assessment of Illicitly Used γ‐Hydroxybutyrate
44. A data-driven quality-score system for rating drug products and its implications for the health care industry.
45. The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases
46. Continued Risk of Dietary Supplements Adulterated With Approved and Unapproved Drugs: Assessment of the US Food and Drug Administration's Tainted Supplements Database 2007 Through 2021
47. Pharmacists Have the Stats but No Provider Status: Now May Be Our Moment
48. A Meta-Analysis Evaluating the Impact of Chitosan on Serum Lipids in Hypercholesterolemic Patients
49. Assessing the Impact of Indexing Performance Measure Codes on the Perceived Value of EPC Reports to Health Systems
50. Response to Letter to the Editor by Dr Robinson
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.